fregime

What actually happened to the stocks you care about: every claim cited, corroboration counted, never opinions.

Development · 21 Aug 2026

MRF, full dossier

MRF's standalone revenue rose 10% year-on-year to ₹8,291.56 crore in Q1FY27, but adjusted profit after tax declined 2% to ₹474.37 crore and EBITDA dropped 8% year-on-year to ₹948.6 crore due to a 570 basis point sequential decline in gross margins to 32.7% from input cost inflation.

1 publisher has reported this development. Each act of reporting is below, cited.

The record

MRF's standalone revenue rose 10% year-on-year to ₹8,291.56 crore in Q1FY27, but adjusted profit after tax declined 2% to ₹474.37 crore and EBITDA dropped 8% year-on-year to ₹948.6 crore due to a 570 basis point sequential decline in gross margins to 32.7% from input cost inflation.

livemint.com30 Jun 2026

MRF's gross margins declined 570 basis points sequentially to 32.7% in Q1FY27 due to intense input cost inflation.

livemint.com30 Jun 2026

MRF

₹1,33,520.00

+0.93%

Close (EOD), as of 26 Aug 2026 · source

Every claim carries its citation

This page is the corroborated record of one development: what each credible source reported, linked and dated. We compile and cite; we do not opine.

fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.